tiprankstipranks
ALX Oncology Holdings (ALXO)
NASDAQ:ALXO
US Market
Holding ALXO?
Track your performance easily

ALX Oncology Holdings (ALXO) Ownership - Who Owns ALX Oncology Holdings?

354 Followers

ALX Oncology Holdings (ALXO) Ownership Overview

3.45%17.63%48.27%6.64%24.02%
48.27% Other Institutional Investors
6.64% ETFs
24.02% Public Companies and
Individual Investors
The ownership structure of ALX Oncology Holdings (ALXO) stock is a mix of institutional, retail, and individual investors. Approximately 72.53% of the company’s stock is owned by Institutional Investors, 3.45% is owned by Insiders, and 24.02% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 16, 2024
Shelly Pinto
Svp, Finance And Cao
xxxxxxxxxxxxx
$1455
Aug 16, 2024
Jaume Pons
President & Cso
xxxxxxxxxxxxx
$4997
Aug 16, 2024
xxxxxxxxxxxxx
$3522
Jul 09, 2024
Shelly Pinto
Svp, Finance And Cao
xxxxxxxxxxxxx
$10008

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$176265

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,136,995Institution7.84%6,081,383
1,655,787Institution3.14%2,434,007
1,603,956Institution3.04%2,357,815
1,265,682Institution2.40%1,860,553
920,239Institution1.74%1,352,751
835,504Institution1.58%1,228,191
591,510Insider1.12%869,520
520,100Institution0.99%764,547
515,894Insider0.98%758,364
495,149Institution0.94%727,869

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,136,995Institution7.84%6,081,383
1,265,682Institution2.40%1,860,553
920,239Institution1.74%1,352,751
835,504Institution1.58%1,228,191
520,100Institution0.99%764,547
495,149Institution0.94%727,869
370,148Institution0.70%544,118
185,506Institution0.35%272,694
166,237Institution0.32%244,368
88,301Institution0.17%129,802

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
984,586Institution1.87%1,407,958
924,328Institution1.75%1,358,762
404,096Institution0.77%577,857
300,558Institution0.57%441,820
198,092Institution0.38%291,195
150,896Institution0.29%215,781
137,366Institution0.26%193,686
83,421Institution0.16%119,292
79,572Institution0.15%116,971
31,868Institution0.06%46,846

FAQ

Who Owns ALX Oncology Holdings (ALXO)?
According to the latest TipRanks data, approximately 48.27% of the company's stock is held by institutional investors, 3.45% is held by insiders, and 24.02% is held by retail investors.
    What percentage of ALX Oncology Holdings (ALXO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 48.27% of ALX Oncology Holdings (ALXO) stock is held by institutional investors.
      What percentage of ALX Oncology Holdings (ALXO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 24.02% of ALX Oncology Holdings (ALXO) stock is held by retail investors.
        Who owns the most shares of ALX Oncology Holdings (ALXO)?
        Fidelity Securities Fund owns the most shares of ALX Oncology Holdings (ALXO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis